000 | 01971 a2200589 4500 | ||
---|---|---|---|
005 | 20250518012849.0 | ||
264 | 0 | _c20190409 | |
008 | 201904s 0 0 eng d | ||
022 | _a1178-2005 | ||
024 | 7 |
_a10.2147/COPD.S178149 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSoler-Cataluña, Juan José | |
245 | 0 | 0 |
_aValidation of clinical control in COPD as a new tool for optimizing treatment. _h[electronic resource] |
260 |
_bInternational journal of chronic obstructive pulmonary disease _c |
||
300 |
_a3719-3731 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Observational Study; Validation Study | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aBronchodilator Agents _xadverse effects |
650 | 0 | 4 | _aClinical Decision-Making |
650 | 0 | 4 | _aDecision Support Techniques |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 |
_aDyspnea _xdiagnosis |
650 | 0 | 4 | _aExercise |
650 | 0 | 4 | _aExercise Tolerance |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aForced Expiratory Volume |
650 | 0 | 4 | _aHealth Status |
650 | 0 | 4 | _aHealth Status Indicators |
650 | 0 | 4 | _aHospitalization |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLung _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aPulmonary Disease, Chronic Obstructive _xdiagnosis |
650 | 0 | 4 | _aReproducibility of Results |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 | _aSputum |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aMarzo, Maribel | |
700 | 1 | _aCatalán, Pablo | |
700 | 1 | _aMiralles, Cristina | |
700 | 1 | _aAlcazar, Bernardino | |
700 | 1 | _aMiravitlles, Marc | |
773 | 0 |
_tInternational journal of chronic obstructive pulmonary disease _gvol. 13 _gp. 3719-3731 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2147/COPD.S178149 _zAvailable from publisher's website |
999 |
_c29145772 _d29145772 |